FLT3 and acute myeloid leukemia: The European Leukemia Net (ELN) 2022 risk classification [5] changed their risk assignment due to the improvement in overall survival (OS) of FLT3mut AML, thanks to the incorporation of FLT3 inhibitors (FLT3i) [6].